Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Issues FY 2021 Earnings Guidance

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) updated its FY 2021 earnings guidance on Tuesday. The company provided EPS guidance of $7.660-$7.900 for the period. The company issued revenue guidance of $51.89 billion-$51.89 billion, compared to the consensus revenue estimate of $51.41 billion.

Several equities research analysts recently commented on the company. Morgan Stanley reissued an overweight rating on shares of Bayer Aktiengesellschaft in a research note on Wednesday, November 10th. AlphaValue raised Bayer Aktiengesellschaft to a buy rating in a research note on Monday, November 15th. JPMorgan Chase & Co. reissued an overweight rating on shares of Bayer Aktiengesellschaft in a research note on Wednesday, November 10th. Kepler Capital Markets reissued a buy rating on shares of Bayer Aktiengesellschaft in a research note on Friday, October 29th. Finally, Berenberg Bank lowered their price target on Bayer Aktiengesellschaft from €74.00 ($84.09) to €60.00 ($68.18) and set a buy rating for the company in a research note on Monday, August 9th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of Buy and an average price target of $39.00.

Bayer Aktiengesellschaft stock traded down $0.41 during trading hours on Thursday, reaching $13.39. 617,463 shares of the company were exchanged, compared to its average volume of 457,803. The firm has a market cap of $52.60 billion, a price-to-earnings ratio of 267.75, a PEG ratio of 2.01 and a beta of 1.23. The company has a current ratio of 1.16, a quick ratio of 0.80 and a debt-to-equity ratio of 1.20. The stock has a 50-day moving average of $13.97 and a 200 day moving average of $14.74. Bayer Aktiengesellschaft has a 12 month low of $13.10 and a 12 month high of $17.34.

About Bayer Aktiengesellschaft

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents.

Featured Article: What is the quiet period?

Earnings History and Estimates for Bayer Aktiengesellschaft (OTCMKTS:BAYRY)

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.